jimmy Turano

Today's Closing Update: Slim Gains Boost Dow

update:'MRNA'`11/13/09... REPORT, COMPANY BEAT CONSENSUS BY TWO CENTS? STILL $-.17 CENTS FOR QTR.
SIGNIFICANT? SPEACH BY CEO RE:CONFERENCE CALL-
THIS IS HOW THEY EARN THEIR MONEY, AND DAY AFTER,
A NEWS RELEASE, REGARDING A LETTER FROM NASDAQ.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On November 6, 2009, the Company received a Staff Deficiency Letter from The Nasdaq Stock Market ("Nasdaq") notifying the Company that for the 10 consecutive trading days ending on November 5, 2009, the aggregate market value of the Company's common stock was below the $50,000,000 minimum market value required for continued listing on the Nasdaq Global Market, as specified by Marketplace Rule 5450(b)(2).
In accordance with Marketplace Rule 5810(c)(3)(C), the Company has 90 calendar days, or until February 4, 2010, to regain compliance with the minimum market value requirement. To regain compliance, the closing market value of the Company's common stock must equal or exceed $50,000,000 for a minimum of 10 consecutive business days or for such longer period that Nasdaq may, in its discretion, require.
If the Company does not regain compliance with the minimum market value requirement by February 4, 2010, Nasdaq will provide the Company written notification that its common stock will be subject to delisting. At that time, the Company may appeal Nasdaq's determination to a Nasdaq Listings Qualifications Panel.
The Staff Deficiency Letter has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Market.
A copy of the press release dated November 12, 2009 announcing receipt of the Staff Deficiency Letter is attached hereto as Exhibit 99.2 and incorporated herein by reference.
WAS THIS DISCUSSED YESTERDAY AT ALL?
DID THEY DISCUSS THE EXPENSE MONEY FOR 2010 AT ALL?
OUT OF SIGHT OUT OF MIND!
IN MY OPINION, THE STOCK CONTINUES ITS 'SOUTH' DIRECTION FROM $1 DOLLAR. TOO MANY NEGATIVES,
TOO EARLY OF A PRE-CLINICAL STAGE COMPANY, AND NO SERIOUS EARNINGS REVENUES WITH EPS GROWTH.
TIMBER!!!!!!!!!!!!!!!!...

Today's Closing Update: Slim Gains Boost Dow

UPDATE:NOV.11TH-RE:'MR... MY CURRENT OPINION HAS BEEN SELECTED TO BE ON TODAYS FRONT PAGE OF
MEDICAL NEWS ADMINISTRATION. SOMETIMES THE LITTLE GUY GETS TO BE HEARD!
www.medicalnewstoday.c...

Today's Closing Update: Slim Gains Boost Dow

'MRNA' NOW $1.07 BEFORE OPENING TODAY, NOV.9TH,2009
FINANCIAL BLOG-WHERE WILL THE COMPANY ATTAIN THE FINANCES TO CONTINUE TO EXIST FOR ALL OF 2010?
NEGATIVES FAR OUTWEIGH THE POSITIVES IN MANY WAYS!
AND EVEN THOUGH THE QTLY REPORT WILL SHOW A LOSS ON NOV.12TH, LISTEN TO CONFERENCE CALL.
YOU WILL HEAR A REAL ORATOR, A PERFORMANCE BY THE CEO TO EARN HIS PAY IN EVERY WAY.
BOTTOM LINE: WHILE STOCK PRICE IS LOW AND SO MANY IN VIVO REPORTS THAT WERE POSITIVE ALL THROUGH 2009, HOW COME INSIDERS DIDN'T BUY UP ANY SHARES?
HOW MANY TIMES MUST MANAGEMENT DODGE THE BULLETS AND COME UP WITH THE MONEY NEEDED TO CONTINUE TO EXIST?

Today's Closing Update: Slim Gains Boost Dow

update:'MRNA' GAINED ON OCT.12, RE:IN VIVO NEWS, BUT NOW HAS RETREATED TO $1.33 AT THE OPENING ON OCT.19TH..
IT IS IN MY OPINION, AFTER FOLLOWING NASTECH FOR 25 YEARS, AND NOW 'MRNA', THAT MRNA IS MORE LIKELY TO
GO DOWN IN STOCK PRICE ABOUT 25% BEFORE YEAR END.
I HAVE BEEN THE ACCURATE POSTER ON SEEKINGALPHA RE:MRNA/NSTK FOR THE LAST 5 YEARS AND ALSO ON OTHER WELL KNOWN INVESTMENT SITES. NUMBERS HAVE TO MAKE SENSE, STATS, EXPENSES, AND EARNINGS REVENUE ARE A VERY BIG PART OF THE OVERALL PICTURE. AND THIS IS WHY I SEE A BEARISH TREND BEFORE YEAR END AND EVEN CARRIED THROUGH UNTIL SPRING OF NEXT YEAR TOO.
HEADED BACK UNDER $1 DOLLAR AGAIN, IN MY OPINION!